City

Houston (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

lenalidomide (1)

ofatumumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

paraproteinemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

Completed

Chronic Lymphocytic Leukemia
+9 more

Lenalidomide
Ofatumumab

Houston, Texas

M D Anderson Cancer Center

Apr 16, 2019